![Hampar L. Karageozian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hampar L. Karageozian
Fundador en Allegro Ophthalmics LLC .
Cargos activos de Hampar L. Karageozian
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Allegro Ophthalmics LLC
![]() Allegro Ophthalmics LLC BiotechnologyHealth Technology Allegro Ophthalmics LLC operates as a biopharmaceutical company. It focuses on the development of novel integrin-regulating therapies for the treatment of ocular diseases. The company was founded by Hampar Karageozian and John Park and is headquartered in San Juan Capistrano, CA. | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | - | - | |
Fundador | 01/01/1993 | - |
Historial de carrera de Hampar L. Karageozian
Antiguos cargos conocidos de Hampar L. Karageozian.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Director Técnico/Científico/I+D | 01/01/1994 | 01/01/1999 |
R&D Services, Inc.
![]() R&D Services, Inc. Engineering & ConstructionIndustrial Services Part of Essar Group, R & D Services, Inc. is a company that provides technical design, installation, and maintenance services for premise cabling. The company is based in Westborough, MA. R&D Services, Inc. was acquired by Black Box Corp., part of Essar Group from January 08, 2019 on January 24, 2000. | Corporate Officer/Principal | - | - |
VitreoRetinal Technologies, Inc.
![]() VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Director Ejecutivo | 01/07/1999 | - |
Fundador | 20/07/2009 | - | |
Allergan Pharmaceuticals Ltd., Inc.
![]() Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Director Técnico/Científico/I+D | - | - |
Corporate Officer/Principal | - | - | |
VG LIFE SCIENCES INC. | Director/Miembro de la Junta | - | - |
Director de Operaciones | - | 21/07/2009 |
Formación de Hampar L. Karageozian.
Massachusetts Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Founder | 2 |
Sectorial
Health Technology | 6 |
Finance | 2 |
Industrial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
VG LIFE SCIENCES INC. | Health Technology |
Empresas privadas | 5 |
---|---|
VitreoRetinal Technologies, Inc.
![]() VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Health Technology |
Allergan Pharmaceuticals Ltd., Inc.
![]() Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Health Technology |
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
R&D Services, Inc.
![]() R&D Services, Inc. Engineering & ConstructionIndustrial Services Part of Essar Group, R & D Services, Inc. is a company that provides technical design, installation, and maintenance services for premise cabling. The company is based in Westborough, MA. R&D Services, Inc. was acquired by Black Box Corp., part of Essar Group from January 08, 2019 on January 24, 2000. | Industrial Services |
Allegro Ophthalmics LLC
![]() Allegro Ophthalmics LLC BiotechnologyHealth Technology Allegro Ophthalmics LLC operates as a biopharmaceutical company. It focuses on the development of novel integrin-regulating therapies for the treatment of ocular diseases. The company was founded by Hampar Karageozian and John Park and is headquartered in San Juan Capistrano, CA. | Health Technology |